OSE Immunotherapeutics SA Financial Overview
OSE Immunotherapeutics SA's market cap is currently €128.53M. The company's EPS TTM is €-0.68; its P/E ratio is -3.54; OSE Immunotherapeutics SA is scheduled to report earnings on October 15, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
